{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:23:41Z","timestamp":1791267821262,"version":"4.1.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>In this study, we compared the cost-effectiveness comparison of the active surveillance (AS) and early surgery (ES) approaches for papillary thyroid microcarcinoma (PTMC) from the perspective of the Chinese healthcare system.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed a cost-effectiveness analysis using a Markov model of PTMC we developed to evaluate the incremental cost-effectiveness ratio of AS and ES. Our reference case was of a 40-year-old woman diagnosed with unifocal (&amp;lt;10\u00a0mm) PTMC. Relevant data were extracted after an extensive literature review, and the cost incurred in each state was determined using China Medicare data on payments for ES and AS. The willingness-to-pay threshold was set at \u00a5242,928\/quality-adjusted life-year (QALY) gained. Sensitivity analyses were performed to account for any uncertainty in the model\u2019s variables. Additional subgroup analyses were performed to determine whether AS was cost-effective when different initial monitoring ages were used.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>ES exhibited an effectiveness of 5.2 QALYs, whereas AS showed an effectiveness of 25.8 QALYs. Furthermore, the incremental cost-effectiveness ratio for ES versus AS was \u00a51,009\/QALY. The findings of all sensitivity analyses were robust. Compared with ES, AS was found to be the cost-effective strategy at initial monitoring ages of 20 and 60 years, with an incremental cost-effectiveness ratio of \u00a53,431\/QALY and \u2212\u00a51,316\/QALY at 20 and 60 years, respectively. AS was a more cost-effective strategy in patients with PTMC aged more than 60.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>With respect to the norms of the Chinese healthcare system, AS was more cost-effective for PTMC over lifetime surveillance than ES. Furthermore, it was cost-effective even when the initial monitoring ages were different. In addition, if AS is incorporated into the management plan for PTMC in China at the earliest possible stage, a predicted savings of \u00a510 \u00d7 10<jats:sup>8<\/jats:sup>\/year could be enabled for every 50,000 cases of PTMC, which indicates a good economic return for future management programs. The identification of such nuances can help physicians and patients determine the best and most individualized long-term management strategy for low-risk PTMC.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1166433","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T09:11:17Z","timestamp":1692349877000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Cost-effectiveness of active surveillance versus early surgery for thyroid micropapillary carcinoma based on diagnostic and treatment norms in China"],"prefix":"10.3389","volume":"14","author":[{"given":"Min","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao Miao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing Qing","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Zhen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(20)30115-7","article-title":"Global trends in thyroid cancer incidence and the impact of overdiagnosis","volume":"8","author":"Li","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(20)30401-0","article-title":"Global patterns and trends in incidence and mortality of thyroid cancer in children and adolescents: a population-based study","volume":"9","author":"Vaccarella","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2019.0684","article-title":"Long-term declines of thyroid cancer mortality: an international age-period-cohort analysis","volume":"30","author":"Li","year":"2020","journal-title":"Thyroid"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2013.0045","article-title":"The increasing incidence of thyroid cancer: the influence of access to care","volume":"23","author":"Morris","year":"2013","journal-title":"Thyroid"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1409841","article-title":"Korea's thyroid-cancer \"epidemic\"\u2013screening and overdiagnosis","volume":"371","author":"Ahn","year":"2014","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.18.2164","article-title":"Increasing incidence of thyroid cancer in the United States, 1973-2002","volume":"295","author":"Davies","year":"2006","journal-title":"JAMA"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28562","article-title":"Annual financial impact of well-differentiated thyroid cancer care in the United States","volume":"120","author":"Lubitz","year":"2014","journal-title":"Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2017.0051","article-title":"2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma","volume":"14","author":"Gao","year":"2017","journal-title":"Cancer Biol Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2019.05.078","article-title":"Surgery alone for papillary thyroid microcarcinoma is less costly and more effective than long term active surveillance","volume":"167","author":"Lin","year":"2020","journal-title":"Surgery"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0568","article-title":"Applying criteria of active surveillance to low-risk papillary thyroid cancer over a decade: how many surgeries and complications can be avoided","volume":"27","author":"Griffin","year":"2017","journal-title":"Thyroid"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2019.0420","article-title":"Patients' View on the management of papillary thyroid microcarcinoma: active surveillance or surgery","volume":"30","author":"Yoshida","year":"2020","journal-title":"Thyroid"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(21)00083-8","article-title":"Mapping overdiagnosis of thyroid cancer in China","volume":"9","author":"Li","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-010-0832-6","article-title":"Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons","volume":"35","author":"Takami","year":"2011","journal-title":"World J Surg"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/sla.0000000000003074","article-title":"Is less more? A microsimulation model comparing cost-effectiveness of the revised American Thyroid Association's 2015 to 2009 guidelines for the management of patients with thyroid nodules and differentiated thyroid cancer","volume":"271","author":"White","year":"2020","journal-title":"Ann Surg"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2017.1442","article-title":"Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance","volume":"143","author":"Tuttle","year":"2017","journal-title":"JAMA otolaryngology\u2013 Head Neck Surg"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1530\/eje-15-0454","article-title":"A cost-effectiveness comparison between early surgery and non-surgical approach for incidental papillary thyroid microcarcinoma","volume":"173","author":"Lang","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1507\/endocrj.EJ16-0381","article-title":"Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid","volume":"64","author":"Oda","year":"2017","journal-title":"Endocr J"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2016.31.3.373","article-title":"The revised 2016 Korean Thyroid Association guidelines for thyroid nodules and cancers: differences from the 2015 American Thyroid Association guidelines","volume":"31","author":"Yi","year":"2016","journal-title":"Endocrinol Metab (Seoul Korea)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0330","article-title":"Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan association of endocrine surgery task force on management for papillary thyroid microcarcinoma","volume":"31","author":"Sugitani","year":"2021","journal-title":"Thyroid"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2022.03.01","article-title":"National guidelines for diagnosis and treatment of thyroid cancer 2022 in China (English version)","volume":"34","year":"2022","journal-title":"Chin J Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.06.035","article-title":"WHO Guide for standardisation of economic evaluations of immunization programmes","volume":"28","author":"Walker","year":"2010","journal-title":"Vaccine"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2013.06.016","article-title":"Routine prophylactic central neck dissection for low-risk papillary thyroid cancer: a cost-effectiveness analysis","volume":"154","author":"Zanocco","year":"2013","journal-title":"Surgery"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2016.06.076","article-title":"Cost-effectiveness of active surveillance versus hemithyroidectomy for micropapillary thyroid cancer","volume":"161","author":"Venkatesh","year":"2017","journal-title":"Surgery"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/lary.28634","article-title":"Total thyroidectomy versus lobectomy in small nodules suspicious for papillary thyroid cancer: cost-effectiveness analysis","volume":"130","author":"Al-Qurayshi","year":"2020","journal-title":"Laryngoscope"},{"key":"B27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.surg.2017.03.028","article-title":"Estimation of the lifetime probability of disease progression of papillary microcarcinoma of the thyroid during active surveillance","volume":"163","author":"Miyauchi","year":"2018","journal-title":"Surgery"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1067\/msy.2001.118370","article-title":"Optimal treatment strategy in patients with papillary thyroid cancer: a decision analysis","volume":"130","author":"Esnaola","year":"2001","journal-title":"Surgery"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s002680010215","article-title":"Total thyroidectomy or thyroid lobectomy in patients with low-risk differentiated thyroid cancer: surgical decision analysis of a controversy using a mathematical model","volume":"24","author":"Kebebew","year":"2000","journal-title":"World J Surg"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2013.06.031","article-title":"Cost analysis of thyroid lobectomy and intraoperative frozen section versus total thyroidectomy in patients with a cytologic diagnosis of \"suspicious for papillary thyroid cancer\"","volume":"154","author":"Leiker","year":"2013","journal-title":"Surgery"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/17.1.112","article-title":"Allowing for differential timing in cost analyses: discounting and annualization","volume":"17","author":"Walker","year":"2002","journal-title":"Health Policy Plan"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2018.0624","article-title":"Longitudinal assessment of quality of life according to treatment options in low-risk papillary thyroid microcarcinoma patients: active surveillance or immediate surgery (Interim analysis of MAeSTro)","volume":"29","author":"Kong","year":"2019","journal-title":"Thyroid"},{"key":"B33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/thy.2013.0367","article-title":"Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation","volume":"24","author":"Ito","year":"2014","journal-title":"Thyroid"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/hed.25706","article-title":"Cost for treatment and follow-up of thyroid cancer increases according to the severity of disease","volume":"41","author":"Kim","year":"2019","journal-title":"Head Neck"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2018.0263","article-title":"Active surveillance of low-risk papillary thyroid microcarcinoma: A multi-center cohort study in Korea","volume":"28","author":"Oh","year":"2018","journal-title":"Thyroid"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2021.05.057","article-title":"Thyroid lobectomy as a cost-effective approach in low-risk papillary thyroid cancer versus active surveillance","volume":"171","author":"Youssef","year":"2022","journal-title":"Surgery"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2015.65.7759","article-title":"Active surveillance for the management of localized prostate cancer (Cancer care ontario guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement","volume":"34","author":"Chen","year":"2016","journal-title":"J Clin Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2021.0679","article-title":"Active surveillance versus immediate surgery for low-risk papillary thyroid microcarcinoma patients in South Korea: A cost-minimization analysis from the MAeSTro study","volume":"32","author":"Kim","year":"2022","journal-title":"Thyroid"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1166433\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T09:11:20Z","timestamp":1692349880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1166433\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,16]]},"references-count":38,"alternative-id":["10.3389\/fendo.2023.1166433"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1166433","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,16]]},"article-number":"1166433"}}